Menu

An expert resource for medical professionals
Provided FREE as a service to women’s health

The Alliance for
Global Women’s Medicine
A worldwide fellowship of health professionals working together to
promote, advocate for and enhance the Welfare of Women everywhere

An Educational Platform for FIGO

The Global Library of Women’s Medicine
Clinical guidance and resources

A vast range of expert online resources. A FREE and entirely CHARITABLE site to support women’s healthcare professionals

The Global Academy of Women’s Medicine
Teaching, research and Diplomates Association

This chapter should be cited as follows:
Fontanella F, Bardi F, et al, Glob. libr. women's med.,
ISSN: 1756-2228; DOI 10.3843/GLOWM.419353

The Continuous Textbook of Women’s Medicine SeriesObstetrics Module

Volume 18

Ultrasound in obstetrics

Volume Editors: Professor Caterina M (Katia) Bilardo, Amsterdam UMC, Amsterdam and University of Groningen, Groningen, The Netherlands
Dr Valentina Tsibizova, PREIS International School, Florence, Italy

Chapter

Evaluation of Fetal Anatomy in the First Trimester

First published: October 2024

Study Assessment Option

By completing 4 multiple-choice questions (randomly selected) after studying this chapter readers can qualify for Continuing Professional Development awards from FIGO plus a Study Completion Certificate from GLOWM
See end of chapter for details

INTRODUCTION

The main applications of first-trimester ultrasound (US) are:

  • Determination of location of pregnancy (intrauterine)
  • Documentation of viability (heart activity)
  • Dating of pregnancy based on the crown–rump length (CRL) measurement1
  • Diagnosis of multiple pregnancy
  • Detection of obvious developmental disorders.

This chapter focuses on first-trimester US in screening for congenital anomalies. The rapid improvement in US imaging has shown that first-trimester US can be used to detect markers of chromosomal anomalies, such as increased nuchal translucency (NT) as part of the combined test (CT) and that certain severe structural anomalies can be detected in the first trimester.2,3 Key to this development was the introduction of transvaginal US which enabled a more detailed visualization of the first-trimester fetus.4,5

The focus was initially on high-risk pregnancies,6 but gradually shifted towards more unselected populations.7

The nuchal scan between 11 and 14 weeks has also become the first global risk profile assessment in pregnancy.8,9,10

The Fetal Medical Foundation (FMF) has played a crucial role in setting standards and providing training and certification for the performance of first-trimester screening.

The two largest studies to date on euploid fetuses examined at the time of the nuchal scan, have shown that structural anomalies are observed in about 1% of cases.7,11 Overall, 43% of the structural anomalies were detected at the first-trimester scan and the NT was enlarged in 30%. The authors state that about one-third of the structural anomalies are amenable to early diagnosis and another 40% can potentially be detected in the first-trimester.7,11 The remaining 30% cannot be detected as these become evident or develop only at later stages in pregnancy.7 The other study confirmed that 45% of the structural anomalies, and 100% of the severe ones, are amenable to early diagnosis. The NT was enlarged in 50% of cases.11 A meta-analysis of 19 studies (115,731 fetuses) on first-trimester US investigation showed an overall detection rate (DR) for structural anomalies of 46%, with 32% of anomalies detected in low-risk pregnancies and 60% in high-risk groups and when a screening protocol was used.12

In 2023, the International Society of Ultrasound in Obstetrics and Gynecology (ISUOG) published an updated guideline addressing the various goals of ultrasound investigation in the first trimester of pregnancy aimed at promoting standardization and uniformity.13

Worldwide, there is a variable policy regarding the offer of a first-trimester ultrasound scan as a first and early step in screening for structural anomalies. There are countries in which this is routinely offered, either as part of the CT or as early screening for anomalies or in the context of research, however, in most countries a national policy is still lacking.

Overall, in an unselected population and in a routine setting, about 40–50% of structural anomalies can potentially be detected in the first trimester, although considerable variations exist among studies, reflecting operator and population characteristics.7,11,14 Severe and often lethal anomalies should be detected in 100% of cases.7,11

Experts recommend that, when possible, first-trimester US should be offered as screening for both chromosomal and structural anomalies and should be carried out according to a structured protocol.12,13 This scan should be regarded as the first global risk profile assessment in pregnancy capable of providing information that cannot be replaced by non-invasive screening for aneuploidies.15

ANATOMICAL SURVEY AT 11+0 TO 13+6 WEEKS

The first-trimester anatomical assessment can present some challenges: although the small fetal size enables quick visualization of different anatomical planes, its mobility can be an obstacle to a thorough examination (Video 1). The use of the cineloop function, if available, can be of great help for this purpose as it can expedite first-trimester US examination. According to the recently published ISUOG guidelines, a distinction can be made between basic first-trimester US investigation and advanced examination.13

1

How to perform an ultrasound examination at 11+0 to 13+6 weeks' gestation (courtesy of the Fetal Medicine Foundation).

BASIC ULTRASOUND EXAMINATION

Table 1 shows items that should be part of any scan performed in the first trimester. A combination of longitudinal and axial planes should be used.

1

Basic first-trimester ultrasound examination (modified from ISUOG Guidelines13). Minimum requirements for scan at 11+0 to 14+0 weeks’ gestation.

Organ/anatomical area

Present and/or normal

Head

Contour/shape of cranium (with no bony defects)

Two brain halves separated by interhemispheric falx

Choroid plexuses almost filling lateral ventricles in their posterior two-thirds (butterfly sign)

Neck

Sagittal view of head and neck: confirm whether nuchal translucency thickness <95th percentile

Chest

Axial view of heart at level of four-chamber view: heart inside chest with regular rhythm

Abdomen

Axial view of abdomen: stomach visible, intact abdominal wall; axial or sagittal view: bladder visible and not dilated

Extremities

Visualize four limbs, each with three segments

Placenta

Ascertain normal appearance of placenta without cystic structures

Biometry

Sagittal view: crown–rump length and nuchal translucency thickness; axial view: biparietal diameter

The examination usually starts with visualization of the whole length of the fetus, in the attempt to measure the CRL (Video 2, Figure 1).

In a longitudinal plane, the fetal head and upper thorax can be displayed in the same plane as used for NT measurement. In this view, the nasal bone (NB) and brain structures including the diencephalon (DE), brainstem (BS) and fourth ventricle with its choroid plexus can also be appreciated (Figure 2).

2

Crown–rump length measurement.

1

Correct crown–rump length measurement: the fetus is stretched and is visualized in the profile view. The head is in a neutral position and the calipers are placed on the crown and at the end of the spine. (Reproduced from International Society of Ultrasound in Obstetrics and Gynecology, with permission.13)

2

Profile view of the fetal head at 13 weeks in the plane used to measure nuchal translucency thickness. (Reproduced from International Society of Ultrasound in Obstetrics and Gynecology, with permission.13)

The fourth ventricle appears as a rectangular structure delimited by two echogenic lines, which has been named intracranial translucency (IT).16 A midsagittal view including the whole fetal trunk, allows visualization of the diaphragm and of the entire abdominal wall and intra-abdominal content, including bladder filling and size. The fetal spine, although not yet completely ossified, can also be observed in its whole extent from the cervical origin to the sacrum (Figure 3). By tilting the probe on both sides of the fetal body the extremities can be visualized, including the three long bony segments of each extremity (Figures 4 and 5). The first-trimester fetus usually has open hands facilitating counting of fingers. The legs are often flexed and the feet can be seen close to each other in a single sweep.

3

Longitudinal view of the entire fetal spine with skin covering. (Reproduced from International Society of Ultrasound in Obstetrics and Gynecology, with permission.13)

4

Coronal view showing both lower extremities (thighs, lower legs and feet). (Reproduced from International Society of Ultrasound in Obstetrics and Gynecology, with permission.13)

5

Axial view through the fetal chest showing both arms (lower arms, hands). (Reproduced from International Society of Ultrasound in Obstetrics and Gynecology, with permission.13)

Axial planes should be obtained starting from the head and moving in the caudal direction. The most cranial axial plane shows the intact skull and in the head the image of the falx (midline) and choroid plexuses. At this stage, these structures almost entirely fill the relatively large lateral ventricles. Of note is that the size of the lateral ventricles (usually 6–8 mm) will not change after 12–13 weeks. The typical appearance of the falx and of the two echogenic structures in the lateral ventricles has been called the ‘butterfly sign’ (Figure 6).17 One plane below this shows the thalami, the cerebral peduncles and the aqueduct (Figure 7), the latter very clearly visible at this stage of pregnancy. This is the plane in which biparietal diameter (BPD) and head circumference (HC) should be measured.

6

Transventricular view showing lateral ventricles with choroid plexuses. (Reproduced from International Society of Ultrasound in Obstetrics and Gynecology, with permission.13)

7

Transthalamic view showing aqueduct (Aq). (Reproduced from International Society of Ultrasound in Obstetrics and Gynecology, with permission.13)

A cross-sectional view of the chest shows the four-chamber view of the heart, in which the size of the atria and ventricles can be appreciated (Figure 8a). The lung fields can also clearly be visualized (Figure 8a). In the same view, the heart axis can be measured (Figure 8b). This should measure between 25° and 65°. The four chambers can also be visualized with color or, even better, directional power Doppler (Figure 9a). Color Doppler is a crucial complement to 2D imaging for rapid visualization of cardiac structures. This includes filling of the chambers, and, if possible, visualization of the crossing of the outflow tracts and confluence of the aortic arch and ductal arches forming a V (V-sign) pointing towards the left shoulder of the fetus with (color) flow in the same direction (Figure 9b). More caudally, the fetal stomach is seen under the heart (Figure 10) just above the level of the umbilical cord insertion into the fetal abdomen (Figure 11). Finally, lower in the pelvis, the bladder is seen (Figures 12 and 13), flanked by the two umbilical arteries (Figure 14). The kidneys can occasionally be observed as two echogenic oval structures on both sides of the spine (Figure 15). This quick and gross anatomical survey enables exclusion of major and most lethal structural anomalies. Although, in favorable circumstances, a transabdominal (TA) scan performed with high resolution US systems gives excellent images, in obese women or when the uterus is retroverted, the TV approach is indicated to improve structure visualization.18 In obese women, a TV US can provide even better images than a TA mid-trimester scan.19

(a)

(b)

8

(a) Axial plane through the chest showing the four-chamber view of the heart. (b) On the same view as that shown in (a), the heart axis is measured, with a line traced from the vertebra to the sternum and a line along the interventricular septum. The angle formed by the intersection of the two lines is then measured.

(a)

(b)

9

(a) Filling of the chambers shown on color Doppler. (b) V-sign formed by the confluence of the ductal and aortic arches. (Reproduced from International Society of Ultrasound in Obstetrics and Gynecology, with permission.13)

10

Axial view of abdomen showing the stomach and umbilical vein (used also for abdominal circumference measurement). (Reproduced with permission from International Society of Ultrasound in Obstetrics and Gynecology, with permission.13)

11

Umbilical cord insertion into the fetal abdomen. (Reproduced with permission from International Society of Ultrasound in Obstetrics and Gynecology, with permission.13)

12

Axial view through the fetal pelvis showing the bladder and the two thighs. (Reproduced with permission from International Society of Ultrasound in Obstetrics and Gynecology, with permission.13)

13

Longitudinal view of the fetal trunk showing the bladder low in the pelvis. (Reproduced with permission from International Society of Ultrasound in Obstetrics and Gynecology, with permission.13)

14

Umbilical arteries (color Doppler) flanking the bladder. (Reproduced with permission from International Society of Ultrasound in Obstetrics and Gynecology, with permission.13)

15

Coronal view through the fetal trunk showing both kidneys. (Reproduced with permission from International Society of Ultrasound in Obstetrics and Gynecology, with permission.13)

Anomalies unlikely to be missed at first-trimester ultrasound examination

According to Syngelaki et al., the fetal structural anomalies below are those that are likely to be recognized at first-trimester US investigation.7

Increased nuchal translucency

Abundant nuchal fluid accumulations (large NT, cystic hygroma, generalized edema) (Video 3) are relatively obvious anomalies that can be associated with aneuploidy.8 When the karyotype is normal, a thickened NT (Figure 16) is a strong marker for structural and genetic disorders and poor pregnancy outcomes.20,21 The chance of a poor outcome depends on the initial degree of enlargement.20 The strongest association exists for cardiac defects,20,21 with NT being enlarged in about 40% of cases with major cardiac defects.22

3

Fetus at 13+3 weeks with large NT and generalized edema and hydrops.

16

Thickened nuchal translucency at 12+5 weeks. (Reproduced with permission from International Society of Ultrasound in Obstetrics and Gynecology, with permission.13)

Of all genetic syndromes, the most frequently associated with increased NT is Noonan syndrome, a relatively common syndrome.23 To diagnose Noonan syndrome, a specific gene panel can be used with next generation sequencing (NGS).24

An enlarged NT is common to many developmental disorders, appearing to be a non-specific US marker shared by different pathways.25,26

The work-up after an enlarged NT with normal karyotype includes array comparative genomic hybridization (CGH) investigation and repeat scans.27 Array CGH can reveal in these fetuses an additional 5–7% of pathological copy number variants.27 Fetal exome sequencing is indicated only in cases in which the NT is >7 mm or with associated anomalies.28 If the nuchal edema has completely disappeared in the second trimester and the 20-week scan is normal, the chance of an abnormal outcome is extremely low and not dissimilar to that of the normal population.29

Acrania (anencephaly)

Acrania, which has a prevalence of about 3.7 : 10,000 pregnancies, is caused by failure of closure of the rostral part of the neural tube. In this condition the cranial bones and scalp skin have not yet developed, and the brain tissue is exposed to mechanical and chemical damage (Video 4). Eventually, brain tissue ‘dissolves’ in the amniotic fluid, producing a milky appearance on the scan. Later in pregnancy acrania evolves into exencephaly and, in the second trimester, into anencephaly, in which hardly any brain tissue is visible. Acrania can be seen in chromosomal or genetic conditions (Meckel-Gruber syndrome) or amniotic band syndrome and is associated with aneuploidy in up to 5% of cases.30 Sonographic features of acrania are present from 9 weeks.31 Usual presentation of acrania at 11–13 weeks is an irregular contour of the head in the sagittal plane and absent or severe deficiency of cranial bones with distortion of the brain structures. In order not to miss this condition, an early scan should be performed after 11 weeks by trained sonographers.32 Other rare conditions that can be diagnosed early in gestation are iniencephaly and craniorachischisis, the latter morphologically similar to acrania. 

4

Acrania at 11 weeks. Absence of cranial bones and severe disorganization of the brain structures.

Encephalocele/cephalocele

Encephalocele/cephalocele (Video 5) (1 : 5000 live births) is a neural tube defect characterized by protrusion of intracranial structures through a defect in the skull. The first-trimester DR is 80%.11 It is suggested that the anomaly is associated with an enlarged rhombencephalic cavity at earlier US investigation and that absence of one of the three posterior brain spaces can be helpful to identify fetuses with cephalocele.33 By visualization of the fetal skull defect in the axial plane, a differentiation can be made between cranial meningocele (protrusion of only meninges; 37% of cases) and encephalocele (protrusion of brain tissue into the cephalocele; 63% of cases).34 

5

Occipital encephalocele at 12 weeks. Posterior skull defect with herniation of mesencephalon and brainstem.

Holoprosencephaly 

Holoprosencephaly (Videos 6 and 7) (1 : 1300 pregnancies)  is characterized by failure of the prosencephalon to divide into two hemispheres, resulting in a single ventricle. The anomaly is often associated with severe skull and facial defects and more than two-thirds of cases are associated with chromosomal abnormalities, mainly trisomies 13 and 18.35

Absence of the butterfly sign and presence of a single brain cavity anteriorly on the axial plane is specific for alobar holoprosencephaly with a high sensitivity.17

Lobar or semilobar holoprosencephaly, however, are more subtle to diagnose and will usually not be detected in the first trimester.

6

Alobar holoprosencephaly: absence of separation between the two hemispheres and fusion of the choroid plexuses

7

Alobar holoprosencephaly at 12 weeks. Single ventricle and absence of midline falx cerebri.

Abdominal wall defects

Abdominal wall defects can easily be diagnosed in the first trimester.11 It is important that the diagnosis is made beyond the phase of physiological gut herniation within the umbilical cord. This is usually complete by about 12 weeks (CRL ≥45 mm).

Exomphalos

The prevalence of exomphalos (omphalocele) (Video 8) at the first-trimester scan is 1 : 419, however, there is a tendency for the prevalence to decrease with advancing gestation and according to the content of the defect.36 Herniation of the liver is rare (1 : 3360) and does not resolve, whereas for herniation of the bowel only (Video 9), the prevalence changes from 1 : 98 at a CRL of 45.0–54.9 mm, to 1 : 798 at a CRL of 55–64.9 mm and 1 : 2073 at a CRL of 65.0–84.0 mm.37,38 The fetal karyotype is frequently abnormal (40.8%) in exomphalos in both liver- (52%) or bowel-only (55%) cases.35 However, if the karyotype is normal, a bowel-only exomphalos has a 92% chance of spontaneous resolution by 20 weeks’ gestation and of an uneventful pregnancy and neonatal outcome. This suggests that in the large majority of bowel-only exomphalos cases diagnosed in the first trimester, this can be regarded as a delayed resolution of the physiological gut herniation within the umbilical cord. Therefore, in cases of low-risk assessment at first-trimester screening or non-invasive prenatal testing (NIPT), no karyotyping is necessary and the diagnosis of exomphalos should be reserved only for cases persisting in the second trimester.35

8

Major exomphalos (omphalocele) at 12+4 weeks: herniation of liver and bowel.

9

Small omphalocele at 12+2 weeks: herniation of bowel only (courtesy of the Fetal Medicine Foundation).

In a recent study of 98 cases of exomphalos diagnosed before 14 weeks’ gestation, 46% were associated with other major structural anomalies: 21.4% had increased NT and 51% of the karyotyped fetuses had chromosomal anomalies, mainly trisomy 18.39 In cases of exomphalos associated with other major structural abnormalities, or with increased NT, the incidence of aneuploidy was 78.9% and 72.2%, respectively. To improve the prognostic value of first-trimester examination, Tassin et al. investigated whether a standardized ratio (mean exomphalos diameter/transverse abdominal diameter) and exomphalos contents were predictive of neonatal morbidity.40 Neonatal morbidity was increased when the ratio was greater than 0.8 or when liver was herniated in the first trimester. The authors concluded that the outcome of exomphalos (92.6% of live born infants survived the neonatal period, 96% without long-term sequelae) is relatively good, but only when isolated and when the ratio is below 0.8. Nine per cent of the fetuses diagnosed with isolated exomphalos before 14 weeks of gestation had severe malformations diagnosed later in pregnancy.39

In conclusion, exomphalos diagnosed in the first trimester, regardless of its size or contents, requires additional investigations to establish the prenatal and postnatal prognosis. When exomphalos is not associated with aneuploidy or other abnormality, its size could be predictive of prenatal and postnatal outcome.

Gastroschisis 

Gastroschisis (Video 10) is observed less frequently than exomphalos at the first-trimester scan, but its prevalence is increasing (from 2.3 to 4.4 : 10,000).11,41 This abdominal wall defect differs from exomphalos in embryological development, associated anomalies, risk factors and outcome. It is characterized by a full-thickness defect of the anterior abdominal wall, typically on the right side of a normally inserted umbilical cord, associated with evisceration of the abdominal contents.42 A recent accredited theory is that gastroschisis may be due to an abnormality of the rudimentary umbilical ring, resulting in a separation of the fetal ectoderm from the amnion’s epithelium on the right side.43 Chronic stress and exposure to domestic violence are risk factors for gastroschisis, moreover mothers of fetuses with gastroschisis are more likely to be younger, smokers and more often users of recreational drugs than are controls.44

Early diagnosis should be made with caution as the physiological gut herniation may mimic the defect or, alternatively, the defects may be missed as the presence of a few bowel loops herniating through a defect located on the right side of a normally inserted umbilical cord may not be seen in the midsagittal plane. The use of transverse planes is therefore indicated.

Management of gastroschisis diagnosed in the first trimester differs from management of exomphalos as, if the defect is isolated, karyotyping is not indicated.43

10

Gastroschisis at 13 weeks. (A, axial plane; B, sagittal plane) the intestinal loops are free floating in the amniotic fluid.

Fetal megacystis

Fetal megacystis is defined as a longitudinal bladder diameter ≥7 mm and is detected in 0.06% of first-trimester scans (Video 11).45 The underlying cause of this rather rare condition ranges from lower urinary tract obstruction (LUTO), to chromosomal abnormalities and congenital syndromes, to transient enlargement with spontaneous resolution and normal urinary system after birth.46,47 In a study of 142 cases of first-trimester megacystis, the outcome was mainly determined by the degree of bladder enlargement: moderate enlargement with a longitudinal diameter <12 mm was associated with spontaneous resolution in euploid fetuses and an increased NT with complex megacystis (chromosomal anomalies or syndromal associations). Severe distension with a longitudinal diameter >15 mm mainly progressed to obstructive uropathy and, when this was associated with an umbilical cord cyst, there was a high likelihood of urethral atresia, a severe condition especially present in female fetuses.47 Therefore, when the bladder diameter is between 7 and 12–15 mm, karyotyping and repeat ultrasound 2 weeks later is recommended.

11

Megacystis at 12+2 weeks. Severe bladder distension. This is an early manifestation of lower urinary tract obstruction obstructive uropathy.

Major developmental disorders

Body stalk anomaly

Body stalk anomaly (Video 12) is characterized by the presence of a major abdominal wall defect and severe kyphoscoliosis, probably the result of a short umbilical cord, in which half of the fetal body lies in the amniotic cavity and the other half is in the celomic cavity. Owing to its severity, the anomaly is usually detected at the first-trimester scan from as early as 11 weeks.48

12

Body stalk anomaly at 11+5 weeks.

Bladder exstrophy, cloacal exstrophy and omphalocele, bladder/cloacal exstrophy, imperforate anus, spina bifida complex (OEIS)

This is a group of rare defects (1 : 30,000–1 : 100,000) of closure of the lower abdominal wall, characterized by protrusion and eversion of the bladder outside the peritoneal cavity and by other major associated defects with derangement of the lower body anatomy. All these defects are characterized by non-visualization of the fetal bladder that, by 12–13 weeks’ gestation, should always be visible. In cases of persistent failure to visualize it, bilateral renal pathology or bladder exstrophy should be suspected.49 When, besides non-visualization of the fetal bladder, other anomalies of the lower part of the body are present (omphalocele, lower abdominal mass, abnormal genitals, lumbosacral spinal defect or a thin-walled intra-abdominal cyst), one of these more complex rare anomalies should be suspected.50

Pentalogy of Cantrell/ectopia cordis

Pentalogy of Cantrell (Video 13) and ectopia cordis are rare but, owing to their distinctive presentation of an extracorporeal heart and common association with increased NT and other anomalies, the defects are amenable to first-trimester diagnosis.51

13

One fetus of a twin pregnancy with pentalogy of Cantrell, at 12+3 weeks.

Conjoined twins

Conjoined twinning (Figure 17) is a rare complication of multiple pregnancy, occurring in 50,000–200,000 pregnancies, with ethnic variations. There are different sorts and degrees of fusion of anatomical structures and the prognosis and therapeutic options very much depend on this.52

17

Conjoined twins at 12+1 weeks.

Molar pregnancy 

In a molar pregnancy, first-trimester ultrasound examination reveals that, in spite of high beta human chorionic gonadotropin (hCG) levels, the fetus has not developed, and the uterus is filled by a mass of cystic structures of variable size. This is defined as complete mole. A partial mole is when the fetus is visible with a normal placenta, but next to it a mass with a typical molar appearance can be seen.53

14

Partial molar pregnancy with a normal fetus at 13+2 weeks.

ADVANCED FIRST-TRIMESTER ULTRASOUND INVESTIGATION

The updated ISUOG guidelines' advice is to follow the basic examination with a more detailed examination of the fetal anatomy, which includes more views.13 Ideally, this should be the case in any first-trimester scan, although the situation is not homogeneous, and local circumstances should be taken into account. The ISUOG protocol for an advanced anatomical assessment in the first trimester is presented in Table 2.

We describe in more detail examination of the brain, neural tube and heart.

2

Anatomical structures that can potentially be visualized on detailed fetal scan at 11+0 to 14+0 weeks’ gestation.13

Anatomical region

Structures that can potentially be visualized

General

Confirm singleton pregnancy

Overview of fetus, uterus and placenta

Head and brain

Calcification of cranium

Contour/shape of cranium (with no bony defects)

Two brain halves separated by interhemispheric falx

Choroid plexuses almost filling lateral ventricles in their posterior two-thirds (butterfly sign)

Thalami, brainstem, cerebral peduncles with aqueduct of Sylvius, intracranial translucency (fourth ventricle), cisterna magna

Face and neck

Forehead, bilateral orbits, nasal bone, maxilla, retronasal triangle, upper lip, mandible

Nuchal translucency thickness

No jugular cysts in neck

Thorax

Shape of the thoracic wall

Lung fields, diaphragmatic continuity

Heart

Heart activity present with regular heart rhythm

Establish situs position: intrathoracic heart position with cardiac axis to left (30°–60°)

Size: one-third of thoracic space

Four-chamber view with two distinct ventricles on gray scale and color Doppler in diastole

Left-ventricular-outflow-tract view on gray scale or color Doppler

Three-vessel-and-trachea view on gray scale or color Doppler

Absence of tricuspid regurgitation/antegrade ductus venosus A-wave on pulsed-wave Doppler

Abdomen

Stomach: normal position in left upper abdomen

Bladder

Normally filled in pelvis (longitudinal diameter <7 mm)

Abdominal wall

Intact with umbilical cord insertion

Two umbilical arteries bordering bladder

Kidneys

Bilateral presence

Spine

Regular shape and continuity of spine

Extremities

Upper limbs with three segments and free movement

Lower limbs with three segments and free movement

Placenta

Size and texture normal, without cystic appearance

Location in relation to cervix and to previous uterine Cesarean section scar

Cord insertion into placenta

Amniotic fluid

Amniotic fluid volume

Membranes

Membrane and chorion dissociated physiologically

First-trimester fetal brain and spine investigation

The importance of early diagnosis of central nervous system (CNS) anomalies lies in the fact that they are common, and often lethal or associated with severe mental disability and/or motor dysfunction. Early detection offers parents the option to terminate the pregnancy at a stage when termination may be less traumatic.54

Neurodevelopment starts from the neurulation phase, from around 19 days of embryonic life to around day 26. The neural plate becomes the neural tube, and this further develops into prosencephalon (forebrain), mesencephalon (midbrain), rhombencephalon (hindbrain) and the spinal cord. Cranial bone ossification should be completed by 11 weeks. At the time of the first-trimester scan (11–13 weeks), rudimentary brain structures are present and can be assessed by ultrasound.55

It is helpful to look specifically for bone ossification in the axial and coronal planes. No bony defects (distortion or disruption) of the skull should be present. Lateral ventricles are relatively large and filled by the echogenic choroid plexuses in their posterior two-thirds. The hemispheres appear symmetrical and separated by a clearly visible interhemispheric fissure and falx (Figures 6 and 7). The thin brain mantle is best appreciated anteriorly, lining the large fluid-filled ventricles, an appearance which should not be mistaken for hydrocephalus. At this early stage, some cerebral structures (e.g. corpus callosum, cerebellum) are not yet sufficiently developed to allow accurate assessment.

The midsagittal view of the fetal head, routinely used for the assessment of NT thickness and NB at 11–13 weeks, can also be used to assess early fetal brain anatomy (Figures 18 and 19). The configuration of the midbrain, brainstem and fourth ventricle changes in cases of open spina bifida (OSB). The intracranial translucency (IT), corresponding to the fourth ventricle, has been proposed as a marker for normal brain development and intact spine.56,57 In fetuses with OSB, the biparietal diameter is affected from as early as the first trimester and is relatively smaller than the head circumference.58,59 Cystic abnormalities of the posterior fossa, suggestive of Dandy–Walker complex can also occasionally be detected.60

18

Profile view of the fetal head at 13 weeks. NB, nasal bone; DE, diencephalon; BS, brainstem; 4thV, intracranial translucency (IT) representing the fourth ventricle.

19

Profile view of the fetal head showing brainstem (yellow line) and brainstem to occipital bone distance (pink line).

There has been some debate as to which view, midsagittal or axial, is the most informative for early investigation of fetal brain abnormalities.61 When anomalies are suspected, the use of transabdominal or transvaginal parallel axial planes and 3D neurosonography, performed by experts, is recommended to reach a final diagnosis.62

Most common brain and neural tube anomalies amenable to first-trimester diagnosis (sometimes detectable)

Open spina bifida (OSB) 

OSB (Video 15) (prevalence in Europe about 1 : 2000 pregnancies) is caused by failure of closure of the neural tube 24–27 days after conception. Typical associated brain changes are due to leakage of cerebrospinal fluid. The developing spinal cord and exposed nerves are damaged by direct trauma and by the neurotoxicity of the amniotic fluid.63 In the first trimester, these secondary changes have just started and are therefore subtle, moreover, the spinal defect and the myelomeningocele (Figure 20) may be challenging to visualize.

15

Fetus with open spina bifida at 13+4 weeks, showing closure defect of the spine and spinal cord (rachischisis)

20

Fetus at 13+4 weeks with lower myelomeningocele in sagittal (left) and coronal (right) views. Calipers indicate the myelomeningocele.

The IT is the most well-known first-trimester marker for OSB, which can be measured in the same plane as that for NT.16 It can be identified in 98% of normal fetuses by trained sonographers, and a meta-analysis of nine studies has indicated that non-visualization of the IT has a sensitivity of 53.5% and specificity of 99.7% for diagnosing OSB.64

To increase sensitivity, numerous approaches have been proposed including measurements of the cisterna magna (CM)65,66,67 the brainstem (BS) and the brainstem occipital bone distance (BSOB)68,69 (Figure 19), or evaluation of the posterior fossa fluid area, and the four-line view69 (Figure 18). Non-visualization of the CM or a CM width below the 5th percentile are both suggested to have a sensitivity for OSB of 50–73%.66,67 In the same image it can be appreciated if one of the three posterior brain spaces is absent and the BSOB distance can be measured. In a retrospective study, a BS diameter above the 95th percentile, a BSOB distance below the 5th percentile, and a BS to BSOB ratio above the 95th percentile had a sensitivity for diagnosing OSB of 96.7%, 86.7%, and 100%, respectively.68 In the only prospective study, the Berlin IT Multicenter Berlin study on 15 526 consecutive patients, experts were able to diagnose all 11 OSB cases based on suspicious findings at the 11–13-week scan, but only by combining all posterior fossa parameters.70 Other markers proposed on the sagittal view include the maxillary occipital line (MO), defined as a straight line drawn along the superior border of the maxilla until it reaches the inner border of the occiput in the midsagittal plane of the fetal face. In cases with OSB, the junction between the midbrain and BS is below the MO line.71,72 Another sign described more recently is the inferior displacement of the torcular Herophili and the larger brainstem–tentorium angle in cases of OSB (Figure 21).73

21

Three recent cranial signs described in first-trimester fetuses with open spina bifida (OSB): A, crash sign;77 B, dry brain;78 C, low torcular herophili.79

Of the markers for OSB evaluated on the axial plane, besides a smaller BPD,58,59 also an altered BPD/transverse abdominal diameter ratio was proposed.74 It was also observed that, due to the loss of cerebrospinal fluid the distance between aqueduct of Silvius (AoS) and occiput is shorter in cases of OSB.75 Cerebrospinal fluid leakage leads to ‘dry brain’ impacting skull and brain morphology of fetuses with OSB.76 Another consequence of this is the posterocaudal displacement of the mesencephalon, called ‘crash sign’ as the midbrain seems to ‘crash’ against the occipital bone.77 Also, when the brain is ‘dry’, the choroid plexus fills the lateral ventricles and occupies a relatively larger area of the fetal head.78

A recent analysis of the various head signs indicates that markers involving changes in the BS and posterior fossa configuration seem superior to others72 (Table 3).

3

Overview of the most studied cranial signs and their sensitivity for detecting open spina bifida.

Head/cranial structure

Criterion

Sensitivity (%)

Axial plane




BPD58,59,72

<5th centile

44–66


BPD/transverse abdominal diameter ratio74

<1

69  


Posterior displacement of mesencephalon (crash sign)77

Juxtaposition of mesencephalon and occipital bone

90.5


Choroid plexus/head size78

Increased ratio

88  

Sagittal plane




IT64,72

Non-visualized;
<5th centile

52–59
(specificity 99.7)


CM70

Non-visualized;
<5th centile

64–73


BS68,72

>95th centile

80–97


BSOB68,72

<5th centile

87–95


BS/BSOB68,72

>95th centile

96  


Maxillo-occipital line (MO)71,72

Junction between the midbrain and brainstem is below the maxillo-occipital line

96  


Inferior displacement of torcular Herophili and brainstem-to-torcular angle79

Low position of torcular Herophili brainstem-to-torcular angle close to 90°

100 (all 22 OSB cases)

However, large prospective studies are still mandatory to define the role of early US in the diagnosis of OSB. It is expected that by combining signs of both sagittal and axial views of the brain (Figures 18, 19 and 21) high DRs of OSB can be achieved.

Dandy–Walker malformation (DWM)

DWM (1 : 30,000 live births) may be suggested by a markedly enlarged intracranial translucency and BSOB, with absence of the septum separating the fourth ventricle and the cisterna magna.60,62 DWM can be associated with chromosomal anomalies or other fetal abnormalities.60,79 A recently described clue for the differential diagnosis of DWM or Blake’s pouch cyst, an innocent anatomical variant, is the position of the choroid plexus of the fourth ventricle.80 Direct assessment of the cerebellar vermis is not possible as its development is completed only at around 18 weeks. Caution should therefore be used in first trimester diagnosis of vermian anomalies and repetition of the US scan until after 18 weeks’ gestation is recommended.

Ventriculomegaly (VM)

Lateral ventricles measuring more than 10 mm are mainly a second- and third-trimester diagnosis. Using again the relationship between choroid plexus size and ventricular size, it has been suggested that it may be possible to diagnose VM as early as in the first trimester, with a sensitivity of 60–70%.81 Lateral ventricles can appear enlarged in first-trimester fetuses with chromosomal anomalies,73 especially trisomies 18 and 13, in some genetic syndromes and in aqueduct stenosis.82 An abducted thumb may suggest X-linked hydrocephalus.83

To summarize, first-trimester diagnosis of conditions such as acrania, alobar holoprosencephaly and encephalocele is possible and these anomalies should actively be excluded at every early scan. Screening for spina bifida is feasible in expert hands with DRs of 50–100% and very low false-positive rates, however, large studies in low-risk populations should indicate which (combination of) markers should be used. All other brain anomalies (mild ventriculomegaly, agenesis of the corpus callosum, migration disorders, tumors, schizencephaly) cannot be diagnosed in early gestation.

Congenital heart defects (CHD)

CHD is the most common malformation (8–10 : 1000 live births). About 30% are severe and responsible for significant mortality and morbidity in the neonatal period and infancy.84

Since the widespread use of NT screening and the recognition of other early markers, first-trimester diagnosis of CHD has been extensively investigated.85 Early fetal echocardiography (EFEC) is commonly offered in high-risk pregnancies or when an increased NT, with or without additional anomalies, is observed at first-trimester screening.86 In high-risk pregnancies, a normal EFEC can provide early reassurance. The challenge is when there is uncertainty regarding the diagnosis. One should be aware that it is never advisable to undertake termination of pregnancy after an early suspicion of CHD and that repetition of the scan at a later stage is always recommended.

Accuracy of CHD detection by early US investigation

A recent systematic review and meta-analysis of 63 studies on early US detection of CHD showed a pooled sensitivity in high- and low-risk women of 68% and 56%, respectively.87

The imaging protocol used for examination was found to have an important impact on screening performance in both populations (P <0.0001), with a significantly higher DR observed in studies using at least one outflow-tract view or color-flow Doppler imaging (both P <0.0001). Early DR varies from 16% for coarctation of the aorta (CoA) and 18% for tetralogy of Fallot (TOF) and transposition of the great arteries (TGA) to 51% for hypoplastic left heart syndrome (HLHS).87 Another recent study, on almost 100 000 pregnancies, found that an early scan could detect >90% of hypoplastic left ventricle cases and atrioventricular septal defects (AVSD) and >60% of complex cardiac anomalies.88

How to perform detailed early fetal echocardiography

Under normal scanning circumstances, all cardiac structures should be visible by 13 weeks (Video 16).89 Although TA examination can allow for a satisfactory examination, in some cases, transvaginal echocardiography can give far better images, especially in women with high BMI.90

16

Color Doppler visualization of the first-trimester heart structures.

In axial views of the chest, the cardiac apex points at 1–2 or 10–11 o’clock for cephalic or breech presentations, respectively. Heart and stomach positions are evaluated to determine the situs. The four-chamber view (4CV) is used to assess the heart axis, symmetry of the ventricles, AV valves and crux. Further tilting of the transducer cranially demonstrates two parallel lines, running from the left ventricle (LV) to the right, representing the left-outflow-tract and, more superiorly, the three-vessel views. The pulmonary artery (PA) runs straight into the ductus arteriosus (DA) and meets the left-sided aorta forming a V-sign. Modern ultrasound systems produce reasonable-quality images of the 4CV in the majority of cases. The resolution can be improved by use of high-frequency probes and of proper image magnification (chest filling at least half of the screen).

The use of color Doppler, with preference for directional power Doppler, and of correct ultrasound settings is essential in early gestation to overcome suboptimal visualization of the heart by grayscale91 (Table 4). However, color Doppler should be used if high velocity flow is suspected (like in TR or aortic stenosis). Color mapping of the great arteries reduces false-negative diagnosis in some CHD.86 The first step is to achieve a good quality 4CV in gray-scale mode and then activate power Doppler. Ventricular filling is seen as two separate red (for apical views) stripes equal in size (Figure 9a, Video 16). The LV stripe forms the apex and is slightly longer than the right ventricle (RV) stripe. With good presets, TR is commonly visible as a blue jet originating in the RV near the interventricular septum. The observation of mild TR is a common finding in the first trimester and likely a normal variant.

4

Suggested machine settings for first-trimester heart examination. Modified from Rieder et al.91

Grayscale

  • Use of highest frequency possible (ideally 9-MHz transabdominal, or 5–9-MHz or 6–12-MHz transvaginal)
  • Narrow the window width to the size of the fetal thorax
  • Magnify the image (fetal thorax should cover >50% of the image)
  • Increase dynamic contrast and gain

Color Doppler

  • Optimize grayscale image first
  • Size of the box should include the entire heart
  • Pulse rate frequency between 20 and 30 cm/s
  • Ultrasound power (usually between 90% and 95%)
  • Filter levels (mid to high) and color gain (the image should display a well-defined blue and/or red flow, without overlapping onto neighboring structures and without aliasing)
  • Directional power Doppler is preferred

By tilting the transducer cranially from the 4CV, the blue stripe of the LVOT is seen. Sometimes the blood velocity in the LVOT is below the scale and it can be better visualized by reducing the pulse repetition frequency (PRF). The next structure seen by sweeping cranially is the long blue stripe formed by the RVOT. A normal PA has a very straight course from the RV into the DA. The vessel appears vertical on the screen. By tilting the transducer further cranially it is possible to see the transverse aorta (aortic arch) on the right side of the PA (opposite to the heart). The PA–DA and Ao meet forming a blue color V-sign pointing towards the left (Figure 9b). When the PA has a straight vertical position, the Ao may not be visible on color Doppler due to the relatively slow blood flow velocity. By reducing gradually the PRF, the V-sign will appear. Earlier in gestation, at 11–12 weeks, the Ao arch is situated higher than the ductal arch and in some cases it is impossible to get a proper V-sign. However, if starting from the DA and continuing the sweep caudally, the blue stripe of the Ao will eventually be seen coming from the right.

Although, to date, no scientific organization recommends a dedicated heart investigation in the late first trimester, there is mounting evidence that some severe heart defects may be recognized at this stage of pregnancy.90,92

The five commonest severe CHD, accounting for more than 80% of cardiac anomalies, are described below and how they can be visualized on EFEC.

Hypoplastic left heart syndrome (HLHS): the typical sonographic appearance of HLHS in the first trimester (Video 17) is absence of a normal 4CV with significant RV > LV disproportion and deviation of the heart axis. On color Doppler, either only the RV filling (Video 17) is seen or both inflows, but with significant RV > LV disproportion. Sometimes the appearance can be complicated by TR and/or mitral valve regurgitation(s). In HLHS the PA is enlarged and straight, there is no V-sign, and retrograde flow in the transverse aorta is seen just above the ductal arch. The velocity of the retrograde flow in the Ao is generally low and, if this is not visible, the PRF and ultrasound power should be gradually reduced. Not all cases of HLHS are amenable to first-trimester diagnosis, as some may result from progression of aortic stenosis into atresia and become apparent only later in pregnancy. Suspicious signs can be RV > LV inflow disproportion and recognition of high velocity flow at the stenotic AV, which can be easily confused with TR. If these signs are observed, the case should be closely followed-up to see whether there is evolution towards HLHS. In expert hands, diagnosis of the most severe forms of HLHS can be as high as 90%, although pooled data report around 73%.11,86,93

17

Hypoplastic left heart syndrome in a 13-week fetus. There is a single right ventricular filling visible.

Atrioventricular septal defects (AVSD) are commonly associated with trisomy 21 (1 in 3) and left atrial isomerism (LAi).87 The condition varies in severity, but a complete AVSD is characterized by a common atrioventricular (AV) junction with a fused multileaflet AV valve. Large AV septal defects are visible on the 4CV (Videos 18a and b). Careful observation of the movements of the common AV valve, especially during diastole, is a diagnostic hint. Color Doppler shows a single ventricular inflow with angled ventricular filling strips, instead of two normal parallel strips. This arrangement is termed ‘trousers sign’ (Video 18). Insufficiency of the common valve is frequent in AVSD and the jet originates from the middle of the heart. In cases of AVSD with normal karyotype, it is important to exclude LAi. This includes complex types of AVSDs, heart block, interrupted IVC with azygos continuation and right-sided stomach.89

(a)
(b)

18

(a) Atrioventricular septal defect (AVSD) in a 12-week fetus with very large nuchal translucency and trisomy 21. (b) Close up on the AVSD, note the deviation of the heart axis (more to the left) and the single inlet to both chambers (courtesy of the Fetal Medicine Foundation)

Transposition of the great arteries (TGA) is one of the most challenging diagnoses even at the mid-trimester scan with less than a 50% DR.94 A great proportion of TGAs have essentially a normal 4CV and normal size of the great arteries. There is interfetal variability regarding the plane in which the parallel course of the great arteries can be visualized (Video 19). Detection of TGA at 11–13 weeks is quoted to be 18%.86 Grayscale US is not helpful in the diagnosis of TGA at 11–13 weeks due to limited resolution and normal 4CV. There are two different presentations of TGA: (1) parallel vessels seen at the level of the outflow tracts and (2) the impression of a 'single' vessel, due to the ‘fusion’ of the color Doppler stripes of the pulmonary artery–ductal arch and the aorta in a sagittal or oblique view. To improve diagnostic ability, we suggest following the course of the great vessels, rather than to look at the three-vessel view. 

19

Transposition of the great arteries in a 12+4-week fetus. Note the parallel course of the great arteries (courtesy of Professor R Chaoui).

Tetralogy of Fallot (TOF) (Video 20) is commonly associated with chromosomal and genetic conditions and extracardiac anomalies. This CHD has typically normal 4CV and normal filling of the ventricles by two parallel stripes. The landmark of TOF is visualization of a large and usually abnormally curved vessel, which arises from the middle of the heart and forms the aortic arch (Video 20). The vessel is seen by grayscale, but even better with color Doppler. Visualization of the PA and DA is often difficult due to their hypoplasia and insufficient resolution. When a VSD and a single overriding vessel are seen at 11–13 weeks, the diagnostic possibilities include TOF, pulmonary atresia, DORV and arterial trunk. These are all severe conotruncal CHD and exclusion of 22q.11 microdeletion is recommended. The pooled early detection rate of TOF is around 40%.87

(a)
(b)

20

(a) Tetralogy of Fallot (TOF) in a 13+5-week fetus. The four-chamber view is normal. (b) The same view with color Doppler. In both, a ventricular septal defect (VSD) is visible, the aorta overrides the VSD and the pulmonary artery is smaller than the aorta.

Coarctation of the aorta (CoA) is a challenging diagnosis at any stage of gestation, due to high rate of false-negative and -positive diagnoses. Suspicion of CoA can arise by observation of disproportion of the ventricles at 11–13 weeks. In 40% of the cases, there is an associated VSD and disproportion may not be evident. Distinction between CoA and interrupted aortic arch at 11–13 weeks may be difficult. The pooled detection rate is around 37%.87

Hypoplastic right heart syndrome (HRHS)

This severe anomaly, much less frequent than HLHS, should be suspected when a single ventricular filling is seen on the right side of the heart. The anomaly is usually caused by pulmonary atresia. Reversed flow in the pulmonary artery trunk may also be present. Despite reported high detection rates (90–100%), this remains an infrequent first-trimester diagnosis.86,87

Other serious CHDs that can be detected in the first-trimester with an abnormal 4CV are Ebstein anomaly (25%) and tricuspid atresia (88%).86 In contrast, diagnosis of DORV, common arterial trunk and right aortic arch may be more challenging as it relies on appreciation of abnormal outflow tracts.86 The use of 4D-spatiotemporal image correlation (STIC) has been proposed as helpful in EFEC. However, with the very active first-trimester fetus, STIC is only feasible with shorter acquisition time.95

To summarize, diagnosis of major CHD at 11–13 weeks is increasingly feasible. Use of a standardized protocol, color flow mapping and training of operators improves early detection of CHD. We expect that, in the future, CHD screening at 11–13 weeks will be based on direct examination of the cardiac morphology, rather than on examination of markers. In all cases, repetition of the scan at 16 weeks and, when there is uncertainty, also later in gestation, is mandatory to reduce false-positive and -negative diagnoses.

Early markers of CHD

The most well-known early marker for CHD is a thickened NT (Figure 16) in the presence of a normal karyotype.22 Other markers such as abnormal ductus venosus (DV) flow and tricuspid regurgitation (TR) are also associated with CHDs.96,97 In some settings, cases with abnormal DV or TR are referred to specialized centers for early detection of CHD. In a meta-analysis, NT ≥95th and ≥99th centile had a pooled sensitivity and specificity for major CHD of 45.6% and 94.7% and of 21% and 99.2%, respectively, with a positive likelihood ratio of 30.22 The risk for CHD increases with increasing NT measurement from 1.6% when the NT is between 2.5 and 3.4 mm, 3.4% when between 3.5 and 4.4 mm, 7.5% when between 4.5 and 5.5 mm, 15% when between 5.5 and 6.4 mm, 19% when between 6.5 and 8.4 mm, and becomes 64% when NT is ≥8.5 mm. All kinds of CHD can be associated with an increased NT, without preference for one defect over another.98

Abnormal ductus venosus (DV) flow 

Abnormal ductus venosus (DV) flow (Video 21) and tricuspid regurgitation (TR) (Video 22) are also commonly seen in fetuses with CHD and increase the sensitivity of NT alone in screening for CHD. The DV can be evaluated by its A-wave (positive, absent, reversed) or PI. Our group found an abnormal DV-PI (≥95th percentile) in two-thirds of fetuses with an increased NT, normal karyotype and CHD with a sensitivity and specificity for detection of CHD of 70% and 62%, respectively.99 There is now consensus that DV-PI measurement is superior to A-wave assessment only, as part of screening algorithms.100 Abnormal DV flow (absent or reversed A-wave during atrial contraction) is a sign of cardiac dysfunction in the second and third trimester.101 A recent study including over 90 000 apparently normal fetuses and 211 with CHD reports that an abnormal DV flow was present in 27.5% of fetuses with CHD.88

Tricuspid regurgitation (Video 22) is also frequently observed in euploid fetuses with CHD.87,97 The mechanism for this association is not clear but it may be related to the reduced diastolic function and high afterload at this gestational age. A recent study found TR in 29% of fetuses with major CHD.88

21

Reversed A-wave in the ductus venosus in a late first-trimester fetus (courtesy of the Fetal Medicine Foundation).

22

Tricuspid regurgitation in a late first-trimester fetus.

Another marker, more recently proposed as sensitive early screening test for CHD, is measurement of the cardiac axis. Normal mean cardiac axis measures 44.5 ± 7.4°. In the CHD group, 74.1%, had an abnormal cardiac axis (110 with left deviation and 19 with right deviation). This marker is suggested to be more sensitive than other first-trimester markers, used alone or in combination, for the detection of major CHD.102

In summary, any one of NT ≥99th percentile, abnormal DV or TR is present in 47% of fetuses with a heart defect and in 3.8% of those without a heart defect. Deviated cardiac axis is seen in ¾ of fetuses with CHD. All these findings should prompt referral for EFEC in specialized centers, even when the NT is normal. The risk of CHD is reduced if these findings are absent.

Other sometimes detectable anomalies

Facial anomalies

Facial anomalies, such as micrognathia (Video 23) and cleft lip/palate, can be diagnosed in the first trimester.11 12 Especially severe cases are readily recognized and the use of angles and other markers can assist in identifying more subtle cases.103,104,105 As micrognathia can resolve later in pregnancy, caution should be used in managing this condition, especially if the genetic work-up is normal. Visualization, on a sagittal view of the face, of an interrupted maxillary bone, the ‘maxillary gap’,106 or absence of the ‘superimposed line’ representing the vomeral bone, have been suggested as markers for a cleft of the palate.107 However, there is still controversy as to which plane, axial or sagittal, is more informative for the first-trimester diagnosis of an isolated cleft of the palate.108 In view of the prevalence and nature of the anomaly, these screening strategies need to be assessed in large prospective studies.

23

Fetus at 12+3 weeks with micrognathia (courtesy of the Fetal Medicine Foundation).

Anomalies of the chest, diaphragm, abdominal wall and bowel

Unilateral or total lung agenesis and laryngeal or tracheal occlusion are rare anomalies, potentially amenable to early prenatal diagnosis in view of their impact on the anatomy of the thorax,11 whereas lesions characterized by an echogenic appearance of the lung, currently grouped under the name congenital pulmonary airway malformation (CPAM), have not been reported earlier than 16 weeks.109 Chronic high airway obstruction syndrome (CHAOS), due to laryngeal or tracheal occlusion, is a usually lethal condition (especially if hydrops is present) leading to increased volume and echogenicity of the lungs, with a visible fluid-filled trachea and flattening or inversion of the diaphragm. The heart appears small and squeezed by the enlarged hyperechoic lungs (Figure 22) and the impaired venous return leads sequentially to ascites, hydrops and heart failure.110 In less severe forms of occlusion, pulmonary enlargement may resolve later in pregnancy. The finding of apparently normal lungs at 11–13 weeks does not exclude CHAOS, because the condition can have delayed manifestations. The association between an enlarged NT and diaphragmatic hernia (CDH) was described in 1997.111 Severe CDH can be associated with nuchal edema, probably owing to impaired venous return due to increased intrathoracic pressure. In left-sided CDH, the stomach can occasionally be seen next to the heart although, in milder cases, it may still be situated intra-abdominally and herniate into the thorax only when, later in pregnancy, the increased intra-abdominal pressure pushes it upwards. In right-sided CDH, the stomach in the first trimester is invariably situated intra-abdominally. In Syngelaki et al. ’s study,7 3/8 cases of CDH in the cohort (37.5%) had an enlarged NT and 4/8 were diagnosed at the 11–13-week scan.

22

Axial view of the chest of a first-trimester fetus with CHAOS (tracheal atresia),  Note the heart squeezed between the enlarged lungs and the ascites.

Anomalies of the abdominal wall have been discussed earlier in this Chapter.

Bowel anomalies can usually only be diagnosed later in pregnancy, however the presence of an intra-abdominal cyst, even if it resolves, may be an early sign of anal atresia.112

Urinary tract and kidney anomalies

Advanced first-trimester examination requires visualization of the kidneys, in addition to assessing normal bladder filling.13 First-trimester kidneys can occasionally appear mildly echogenic (Figure 15), which is a normal variant.

A normal amount of amniotic fluid in early pregnancy does not exclude a severe genitourinary anomaly with no urine production. It is only after 16 weeks that the major contribution to the volume of amniotic fluid is fetal urination and therefore oligohydramnios can only become apparent from the 17th week.113 Fetal bladder filling should be visible from 10–11 weeks onwards. Megacystis was discussed earlier in this Chapter.

First-trimester examination detects the majority of lower urinary tract obstruction and a few cases of bilateral or unilateral renal agenesis and polycystic kidneys. Overall, about 70% of these anomalies are diagnosed in the first trimester, but none of multicystic kidneys, hydronephrosis, duplex or horseshoe kidneys, megaureter or renal cysts is amenable to first-trimester diagnosis.11,12

When bilateral large hyperechoic kidneys are seen, variably associated with an occipital encephalocele and postaxial polydactyly, Meckel-Gruber syndrome should be suspected.114 The diagnosis of Meckel-Gruber syndrome is supposed to be easier at this stage, since later in pregnancy the presence of oligohydramnios may hinder visualization of polydactyly and encephalocele.

Skeletal anomalies

Severe skeletal anomalies can be suspected in the first trimester. These conditions are often associated with thickened NT.11,12,115 Non-invasive diagnosis of skeletal anomalies is also becoming increasingly available and this can be applied as soon as the suspicion arises.116 Non-invasive prenatal sequencing for multiple Mendelian monogenic disorders (NIPS-M) is currently also experimented among fetuses with skeletal abnormalities or increased nuchal translucency (NT), although the last group may have already undergone invasive prenatal diagnosis in most cases.117

Genetic syndromes

Some typical phenotypic expressions of known genetic syndromes may be visible by the time of the early US scan. When parents are known carriers of genetic syndromes with a dominant or recessive inheritance pattern, expert US investigation from the first trimester, alone or in combination with targeted genetic testing, may help to confirm or exclude the (re-) occurrence of the syndrome in offspring and reduce the period of uncertainty.

Many fetal syndromes have been diagnosed in fetuses with a, usually severely, increased NT and normal chromosomes.23,29 Thus far, a clear association with thickened NT has been confirmed for Noonan syndrome (NS) and other RASopathies, and diagnostic protocols have been suggested.24,28 Some of the phenotypic features typical of NS may already be visible from early in pregnancy (Figure 23). Typical patterns of NT and serum markers have also been proposed for the early diagnosis of 22q11 deletion.118 A breakthrough in the early diagnosis of fetal syndromes has been the introduction of trio whole exome sequencing (WES) in the prenatal work-up of fetuses with structural anomalies, although experience with anomalies diagnosed in the first trimester is still limited.119,120

23

Three-dimensional ultrasound images of the face of a fetus with Noonan syndrome. Note the small mouth (a) and low position of the ears (b).

SAFETY AND ETHICAL CONSIDERATIONS

Thanks to continuous improvement in US technology (high-frequency probes with excellent resolution) and the widespread use of ultrasound at 11–14 weeks, early diagnosis of structural anomalies is increasingly possible. Transvaginal US often provides even better imaging. Importantly there is no scientific evidence that US in the first trimester may be harmful, provided that the thermal indices are kept within acceptable ranges and color and spectral Doppler modalities are used under the principle of ‘as low as reasonably achievable’ (ALARA).13 Exposure of young fetuses to prolonged Doppler examination should always be avoided. The advantages of an early diagnosis are evident, as it allows time for repeat US scans, additional genetic investigations and for parents to consider their options, including termination of pregnancy. It is important to know that certain findings, such as a thickened NT, bowel herniation or megacystis may be transient and not associated with an unfavorable outcome. Caution in making certain diagnoses or excluding anomalies at such an early stage is recommended as the situation may change at repeat examinations.

Experience, training and adherence to protocols, are key to good performance of first-trimester US.12,13,92

Women greatly value the opportunity of early diagnosis of structural anomalies or early reassurance. However, they should be informed of the shortcomings of ultrasound diagnosis at this early stage of pregnancy.121

FUTURE OF THE EARLY ANATOMY SCAN

Current worldwide practice regarding the performance of first-trimester anatomy scans is still very variable and more uniformity is warranted.122 The decrease in cost of cfDNA will inevitably lead to the widespread adoption of this screening method as an integral part of prenatal screening, from as early as 10 weeks’ gestation. It is important for practitioners to understand that this test cannot replace and should be combined with a first-trimester scan for the diagnosis of fetal structural anomalies and evaluation of the NT, undoubtedly the strongest marker of abnormal fetal development.23,123,124

Further developments in elaboration of US data and other technologies, such as virtual reality and artificial intelligence will no doubt soon be available, from as early as the first trimester.125,126 These and similar developments will facilitate detection of abnormal embryological and fetal development, from an increasingly earlier stage (9–10 weeks’ gestation).127

We expect that, in the future, tailored genetic and (preconceptional) risk-profile assessment, combined with early US investigations, cfDNA and, where indicated, invasive testing to perform advanced genetic diagnostic methods (WES), will provide at-risk couples with timely information regarding the health of their offspring, and also regarding the chance of future pregnancy complications.

CONCLUSION

The performance of first-trimester diagnosis for anomalies is good, provided experienced sonographers follow a protocol and the examination takes place beyond 12 weeks’ gestation. Training programs and certification for first-trimester US, as for second-trimester US, should become available. The number of false positives is not high at this first-trimester scan and, with increasing experience, fewer referrals may be necessary.14,128

Many severe and often lethal anomalies are amenable (always detectable) to early diagnosis and increasingly more of the sometimes detectable are diagnosed early in pregnancy.14,92 This enables couples to make reproductive choices at an earlier stage, when termination of pregnancy, in addition to being less traumatic, is safer129. Even in the era of cfDNA, an early fetal anatomical evaluation (including NT assessment) remains an essential component of screening for congenital defects and early risk assessment for pregnancy complications.

PRACTICE RECOMMENDATIONS

  • Whenever a first-trimester scan is performed for dating of pregnancy or nuchal translucency screening or prior to cell-free fetal DNA investigation, it is mandatory that the fetal anatomy is also checked.
  • Depending on the local circumstances and resources (time allocated, equipment available), this can happen as a “basic” examination with a limited number of anatomical views or as an “advanced” examination, with a more detailed examination of the fetal anatomy.
  • The majority of severe, often lethal, anomalies can be detected at first-trimester examination (“always” detectable anomalies). These account for about 30% of the total of fetal anomalies.
  • Another 40% of fetal anomalies are “sometimes” detected in the first trimester. With more experience in first-trimester anatomical assessment and systematic use of anatomical markers, it is expected that more anomalies will be detected in the first trimester and the percentage of “sometimes” detected anomalies will decrease in favor of the “always” detectable ones.
  • Advantage of early detection of anomalies is that it allows more time for additional investigations and counseling.
  • When severe anomalies are detected, women value highly the possibility of an early termination of pregnancy.
  • An early termination of pregnancy, besides being psychologically less traumatic, is also safer compared to a later termination of pregnancy.


CONFLICTS OF INTEREST

The author(s) of this chapter declare that they have no interests that conflict with the contents of the chapter.

REFERENCES

1

Robinson HP, Fleming JE. A critical evaluation of sonar "crown-rump length" measurements. Br J Obstet Gynaecol. 1975;82(9):702–710.

2

Nicolaides KH, Azar G, Byrne D, Mansur C, Marks K. Fetal nuchal translucency: ultrasound screening for chromosomal defects in the first trimester of pregnancy. BMJ. 1992;304(6831):867–869.

3

Romero R, Jeanty P, Hobbins JC. Diagnostic ultrasound in the first trimester of pregnancy. Clin Obstet Gynecol. 1984;27(1):286–313.

4

Rottem S, Bronshtein M, Thaler I, Filmar S. First-trimester transvaginal sonographic diagnosis of fetal anomalies. Lancet. 1989;1(8639):444–445.

5

Achiron R, Tadmor O. Screening for fetal anomalies during the first trimester of pregnancy: transvaginal versus transabdominal sonography. Ultrasound Obstet Gynecol. 1991;1(3):186–191.

6

Yagel S, Achiron R, Ron M, Valsky DV, Cohen SM, Ben Rafael Z. Transvaginal ultrasonography at early pregnancy cannot be used alone for targeted organ ultrasonographic examination in a high-risk population. Am J Obstet Gynecol. 1995;172(1 Pt 1):63–69.

7

Syngelaki A, Chelemen T, Dagklis T, Allan L, Nicolaides KH. Challenges in the diagnosis of fetal non-chromosomal abnormalities at 11–13 weeks. Prenat Diagn. 2011;31(1):90–102.

8

Snijders RJ, Noble P, Sebire N, Souka A, Nicolaides KH; Fetal Medicine Foundation First Trimester Screening Group. UK multicentre project on assessment of risk of Trisomy 21 by maternal age and fetal nuchal translucency thickness at 10–14 weeks of gestation. Lancet. 1998;352(9125):343–346.

9

Nicolaides KH. A model for a new pyramid of prenatal care based on the 11 to 13 weeks' assessment. Prenat Diagn. 2011;31(1):3–6.

10

Kagan KO, Wright D, Baker A, Sahota D, Nicolaides KH. Screening for trisomy 21 by maternal age, fetal nuchal translucency thickness, free beta human chorionic gonadotropin, and pregnancy-associated plasma protein-A. Ultrasound Obstet Gynecol. 2008;31(6):618–624.

11

Syngelaki A, Hammami A, Bower S, Akolekar R, Nicolaides KH. Diagnosis of fetal non-chromosomal abnormalities on routine ultrasound examination at 11–13 weeks' gestation. Ultrasound Obstet Gynecol. 2019;54(4):468–476.

12

Karim JN, Roberts NW, Salomon LJ, Papageorghiou AT. Systematic review of first-trimester ultrasound screening for detection of fetal structural anomalies and factors that affect screening performance. Ultrasound Obstet Gynecol. 2017;50(4):429–441.

13

International Society of Ultrasound in Obstetrics and Gynecology. Bilardo CM, Chaoui R, Hyett JA, Kagan KO, Karim JN, Papageorghiou AT, Poon LC, Salomon LJ, Syngelaki A, Nicolaides KH. ISUOG Practice Guidelines (updated): performance of 11–14-week ultrasound scan. Ultrasound Obstet Gynecol. 2023;61(1):127–143.

14

Kenkhuis MJA, Bakker M, Bardi F, Fleurke-Rozema H, Pajkrt E, Bilardo CM. Effectiveness of 12–13-week scan for early diagnosis of fetal congenital anomalies in the cell-free DNA era. Ultrasound Obstet Gynecol. 2018;51(4):463–469.

15

Alfirevic Z, Bilardo CM, Salomon LJ, Syngelaki A, Nicholas SR, To MS. Women who choose cell-free DNA testing should not be denied first-trimester anatomy scan. BJOG. 2017;124(8):1159–1161.

16

Chaoui R, Benoit B, Mitkowska-Wozniak H, Heling KS. Assessment of intracranial translucency (IT) in the detection of spina bifida at the 11–13-week scan. Ultrasound Obstet Gynecol. 2009;34(3):249–252.

17

Sepulveda W, Dezerega V, Be C. First-trimester sonographic diagnosis of holoprosencephaly: value of the “butterfly” sign. J Ultrasound Med. 2004;23(6):761–765.

18

Ebrashy A, El Kateb A, Momtaz M, Nada A, El Said G, Kotb A. 13–14-week fetal anatomy scan: a 5-year prospective study. Ultrasound Obstet Gynecol. 2010;35(3):292–296.

19

Buskmiller C, Fishel Bartal M, Bonilla M, Denham C, Nguyen R, Sibai B, Pedroza C, Hernandez-Andrade E. First trimester anatomy ultrasound for patients with obesity: a randomized controlled trial. Am J Obstet Gynecol MFM. 2023;5(11):101143.

20

Souka AP, Von Kaisenberg CS, Hyett JA, Sonek JD, Nicolaides KH. Increased nuchal translucency with normal karyotype. Am J Obstet Gynecol. 2005;192(4):1005–1021.

21

Bilardo CM, Pajkrt E, de Graaf I, Mol BW, Bleker OP. Outcome of fetuses with enlarged nuchal translucency and normal karyotype. Ultrasound Obstet Gynecol. 1998;11(6):401–406.

22

Sotiriadis A, Papatheodorou S, Eleftheriades M, Makrydimas G. Nuchal translucency and major congenital heart defects in fetuses with normal karyotype: a meta-analysis. Ultrasound Obstet Gynecol. 2013;42(4):383–389.

23

Bardi F, Bosschieter PF, Verheij JB, Bilardo CM, Pajkrt E. Is there still a role for nuchal translucency measurement in the changing paradigm of first trimester screening? Prenat Diagn. 2020;40(2):197–205.

24

Stuurman KE, Joosten M, van der Burgt I, Elting M, Yntema HG, Meijers-Heijboer H, Rinne T.Prenatal ultrasound findings of rasopathies in a cohort of 424 fetuses: update on genetic testing in the NGS era. J Med Genet. 2019;56(10):654–661.

25

Haak MC, van Vugt JM. Pathophysiology of increased nuchal translucency: a review of the literature. Hum Reprod Update. 2003;9(2):175–184.

26

Allan LD. The mystery of the nuchal translucency. The Mannheimer Lecture. Cardiol Young. 2006;16(1):11–17.

27

Grande M, Jansen FA, Blumenfeld YJ, Fisher A, Odibo AO, Haak MC, Borrell A. Genomic microarray in fetuses with increased nuchal translucency and normal karyotype: a systematic review and meta-analysis. Ultrasound Obstet Gynecol. 2015;46(6):650–658.

28

Mellis R, Eberhardt RY, Hamilton SJ; PAGE Consortium; McMullan DJ, Kilby MD, Maher ER, Hurles ME, Giordano JL, Aggarwal V, Goldstein DB, Wapner RJ, Chitty LS. Fetal exome sequencing for isolated increased nuchal translucency: should we be doing it? BJOG. 2022;129(1):52–61.

29

Bilardo CM, Müller MA, Pajkrt E, Clur SA, van Zalen MM, Bijlsma EK. Increased nuchal translucency thickness and normal karyotype: time for parental reassurance. Ultrasound Obstet Gynecol. 2007;30(1):11–18.

30

Chen CP. Chromosomal abnormalities associated with neural tube defects (I): full aneuploidy. Taiwan J Obstet Gynecol. 2007;46(4):325–335.

31

Becker R, Mende B, Stiemer B, Entezami M. Sonographic markers of exencephaly at 9 + 3 weeks of gestation. Ultrasound Obstet Gynecol. 2000;16(6):582–584.

32

Fleurke-Rozema JH, van Leijden L, van de Kamp K, Pajkrt E, Bilardo CM, Snijders RJ. Timing of detection of anencephaly in The Netherlands. Prenat Diagn. 2015;35(5):483–485.

33

Volpe N, Dall'Asta A, Di Pasquo E, Frusca T, Ghi T. First-trimester fetal neurosonography: technique and diagnostic potential. Ultrasound Obstet Gynecol. 2021;57(2):204–214.

34

Sepulveda W, Wong AE, Andreeva E, Al-Kouatly HB. Sonographic spectrum of first-trimester fetal cephalocele: review of 35 cases. Ultrasound Obstet Gynecol. 2015;46(1):29–33.

35

Syngelaki A, Guerra L, Ceccacci I, Efstratiadis G, Nicolaides KH. Impact of holoprosencephaly, exomphalos, megacystis and increased nuchal translucency on first-trimester screening for chromosomal abnormalities. Ultrasound Obstet Gynecol. 2017;50(1):45–48.

36

Iacovella C, Contro E, Ghi T, Orlandi E, De Musso F, Volpe G. The effect of the contents of exomphalos and nuchal translucency at 11–14 weeks on the likelihood of associated chromosomal abnormality. Prenat Diagn. 2012;32(11):1066–1070.

37

Snijders RJ, Sebire NJ, Souka A, Santiago C, Nicolaides KH. Fetal exomphalos and chromosomal defects: relationship to maternal age and gestation. Ultrasound Obstet Gynecol. 1995;6(4):250–255.

38

Kagan KO, Staboulidou I, Syngelaki A, Cruz J, Nicolaides KH. The 11–13-week scan: diagnosis and outcome of holoprosencephaly, exomphalos and megacystis. Ultrasound Obstet Gynecol. 2010;36(1):10–14.

39

Khalil A, Arnaoutoglou C, Pacilli M, Szabo A, David AL, Pandya P. Outcome of fetal exomphalos diagnosed at 11–14 weeks of gestation. Ultrasound Obstet Gynecol. 2012;39(4):401–406.

40

Tassin M, Descriaud C, Elie C, Houfflin Debarge V, Dumez Y, Perrotin F, Benachi A. Omphalocele in the first trimester: prediction of perinatal outcome. Prenat Diagn. 2013;33(5):497–501.

41

Kirby RS, Marshall J, Tanner JP, Salemi JL, Feldkamp ML, Marengo L, Meyer RE, Druschel CM, Rickard R, Kucik JE; National Birth Defects Prevention Network. Prevalence and correlates of gastroschisis in 15 states, 1995 to 2005. Obstet Gynecol. 2013;122(2 Pt 1):275–281.

42

Tassin M, Benachi A. Diagnosis of abdominal wall defects in the first trimester. Curr Opin Obstet Gynecol. 2014;26(2):104–109.

43

Bhat V, Moront M, Bhandari V. Gastroschisis: A State-of-the-Art Review. Children (Basel). 2020;7(12):302.

44

Ortega-García JA, Soldin OP, Sánchez-Sauco MF, Cánovas-Conesa A, Gomaríz-Peñalver V, Jaimes-Vega DC, Perales JE, Cárceles-Alvarez A, Martínez-Ros MT, Ruiz D. Violence against women and gastroschisis: a case-control study. Int J Environ Res Public Health. 2013;10(10):5178–5190.

45

Liao AW, Sebire NJ, Geerts L, Cicero S, Nicolaides KH. Megacystis at 10–14 weeks of gestation: chromosomal defects and outcome according to bladder length. Ultrasound Obstet Gynecol. 2003;21(4):338–341.

46

Fontanella F, Duin L, Adama van Scheltema PN, Cohen-Overbeek TE, Pajkrt E, Bekker M, Willekes C, Bax CJ, Oepkes D, Bilardo CM. Fetal megacystis: prediction of spontaneous resolution and outcome. Ultrasound Obstet Gynecol. 2017;50(2):242–247.

47

Fontanella F, Duin L, Adama van Scheltema PN, Cohen-Overbeek TE, Pajkrt E, Bekker M, Willekes C, Bax CJ, Oepkes D, Bilardo CM. Antenatal workup of early megacystis and selection of candidates for fetal therapy. Fetal Diagn Ther. 2019;45(3):155–161.

48

Smrcek JM, Germer U, Krokowski M, Berg C, Krapp M, Geipel A, Gembruch U. Prenatal ultrasound diagnosis and management of body stalk anomaly: analysis of nine singleton and two multiple pregnancies. Ultrasound Obstet Gynecol. 2003;21(4):322–328.

49

Gearhart JP, Ben-Chaim J, Jeffs RD, Carr MC, Diamond DA, Kaplan GW. Criteria for the prenatal diagnosis of classic bladder exstrophy. Obstet Gynecol. 1995;85(6):961–964.

50

Wax JR, Pinette MG, Smith R, Cartin A, Blackstone J. First-trimester prenatal sonographic diagnosis of omphalocele-exstrophy-imperforate anus-spinal defects complex. J Clin Ultrasound. 2009;37(3):171–174.

51

Grigore M, Micu R, Matasariu R, Duma O, Chicea AL, Chicea R. Cantrell syndrome in the first trimester of pregnancy: imagistic findings and literature review. Med Ultrason. 2020;22(2):189–196.

52

Maymon R, Mendelovic S, Schachter M, Dirnfeld M, Lessing JB. Diagnosis of conjoined twins before 16 weeks' gestation: The 4-year experience of one medical center. Prenat Diagn. 2005;25(9):839–843.

53

Ross JA, Unipan A, Clarke J, Magee C, Johns J. Ultrasound diagnosis of molar pregnancy. Ultrasound. 2018;26(3):153–159.

54

Korenromp MJ, Christiaens GC, van den Bout J, Mulder EJ, Hunfeld JA, Bilardo CM, Offermans JP, Visser GH. Long-term psychological consequences of pregnancy termination for fetal abnormality: a cross-sectional study. Prenat Diagn. 2005;25(3):253–260.

55

Blaas HG, Eik-Nes SH. Sonoembryology and early prenatal diagnosis of neural anomalies. Prenat Diagn. 2009;29(4):312–325.

56

Chaoui R, Benoit B, Mitkowska-Wozniak H, Heling KS, Nicolaides KH. Assessment of intracranial translucency (IT) in the detection of spina bifida at the 11–13-week scan. Ultrasound Obstet Gynecol. 2009;34(3):249–252.

57

Chaoui R, Benoit B, Heling KS, Nicolaides KH. Prospective detection of open spina bifida at 11–13 weeks by assessing intracranial translucency and posterior brain. Ultrasound Obstet Gynecol. 2011;38(6):722–726.

58

Bernard JP, Cuckle HS, Stirnemann JJ, Salomon LJ, Ville Y. Screening for fetal spina bifida by ultrasound examination in the first trimester of pregnancy using fetal biparietal diameter. Am J Obstet Gynecol. 2012;207(4).

59

Khalil A, Coates A, Papageorghiou A, Bhide A, Thilaganathan B. Biparietal diameter at 11–13 weeks’ gestation in fetuses with open spina bifida. Ultrasound Obstet Gynecol. 2013;42(4):409–415.

60

Volpe P, Contro E, Fanelli T, Muto B, Pilu G, Gentile M. Appearance of fetal posterior fossa at 11–14 weeks in fetuses with Dandy-Walker malformation or chromosomal anomalies. Ultrasound Obstet Gynecol. 2016;47(6):720–725.

61

Chaoui R, Nicolaides KH. Detecting open spina bifida at the 11–13-week scan by assessing intracranial translucency and the posterior brain region: midsagittal or axial plane? Ultrasound Obstet Gynecol. 2011;38(6):609–612.

62

Volpe N, Dall'Asta A, Di Pasquo E, Frusca T, Ghi T. First-trimester fetal neurosonography: technique and diagnostic potential. Ultrasound Obstet Gynecol. 2021;57(2):204–214.

63

Sival DA, Begeer JH, Staal-Schreinemachers AL, van der Werf GK, Arts WF, Wal Gv. Perinatal motor behaviour and neurological outcome in spina bifida aperta. Early Hum Dev. 1997;50(1):27–37.

64

Maruotti GM, Saccone G, D'Antonio F, Berghella V, Sarno L, Morlando M, Giudicepietro A, Martinelli P. Diagnostic accuracy of intracranial translucency in detecting spina bifida: a systematic review and meta-analysis. Prenat Diagn. 2016;36(11):991–996.

65

Karl K, Heling KS, Chaoui R. Fluid area measurements in the posterior fossa at 11–13 weeks in normal fetuses and fetuses with open spina bifida. Fetal Diagn Ther. 2015;37(4):289–293.

66

Garcia-Posada R, Eixarch E, Sanz M, Figueras F, Gratacós E. Cisterna magna width at 11–13 weeks in the detection of posterior fossa anomalies. Ultrasound Obstet Gynecol. 2013;41(5):515–520.

67

Mangione R, Dhombres F, Lelong N, Bernard JP, Ville Y, Salomon LJ. Screening for fetal spina bifida at the 11–13-week scan using three anatomical features of the posterior brain. Ultrasound Obstet Gynecol. 2013;42(4):416–420.

68

Lachmann R, Chaoui R, Moratalla J, Picciarelli G, Nicolaides KH. Posterior brain in fetuses with open spina bifida at 11 to 13 weeks. Prenat Diagn. 2011;31(2):103–106.

69

Iuculano A, Zoppi MA, Piras A, Marongiu M, Monni G. Brain stem/brain stem occipital bone ratio and the four-line view in nuchal translucency images of fetuses with open spina bifida. J Matern Fetal Neonatal Med. 2014;27(14):1–4.

70

Chen FC, Gerhardt J, Entezami M, Müller C, Krapp M, Merz E. Detection of spina bifida by first-trimester screening – results of the prospective multicenter Berlin IT study. Ultraschall Med. 2015;36(5):490–496.

71

Ramkrishna J, Araujo Junior E, Peixoto AB, Da Silva Costa F, Meagher S. Maxillo-occipital line: a sonographic marker for screening of open spina bifida in the first trimester of pregnancy. J Matern Fetal Neonatal Med. 2019;32(24):4073–4079.

72

Wertaschnigg D, Ramkrishna J, Ganesan S, Tse C, Scheier M, Volpe N, Ghi T, Meagher S, Rolnik DL. sonographic markers of fetal open spina bifida at 11 to 13 weeks of gestation. Prenat Diagn. 2020 Feb;40(3):365–372.

73

Volpe P, De Robertis R, Fanelli T, Boito S, Volpe G, Votino C, Persico N, Chaoui R. Low torcular Herophili position and large brainstem-tentorium angle in fetuses with open spinal dysraphism at 11–13 weeks' gestation. Ultrasound Obstet Gynecol. 2022 Jan;59(1):49–54.

74

Simon EG, Arthuis CJ, Haddad G, Bertrand P, Perrotin F. Biparietal/transverse abdominal diameter ratio ≤1: potential marker for open spina bifida at 11–13-week scan. Ultrasound Obstet Gynecol. 2015 Mar;45(3):267–272.

75

Finn M, Sutton D, Atkinson S, Ransome K, Sujenthiran P, Ditcham V, Wakefield P, Meagher S. The aqueduct of Sylvius: a sonographic landmark for neural tube defects in the first trimester. Ultrasound Obstet Gynecol. 2011 Dec;38(6):640–645.

76

Loureiro T, Ushakov F, Montenegro N, Gielchinsky Y, Nicolaides KH. Cerebral ventricular system in fetuses with open spina bifida at 11–13 weeks' gestation. Ultrasound Obstet Gynecol. 2012 Jun;39(6):620–624.

77

Ushakov F, Sacco A, Andreeva E, Tudorache S, Everett T, David AL, Pandya PP. Crash sign: new first-trimester sonographic marker of spina bifida. Ultrasound Obstet Gynecol. 2019 Dec;54(6):740–745.

78

Chaoui R, Benoit B, Entezami M, Frenzel W, Heling KS, Ladendorf B, Pietzsch V, Sarut Lopez A, Karl K. Ratio of fetal choroid plexus to head size: simple sonographic marker of open spina bifida at 11–13 weeks' gestation. Ultrasound Obstet Gynecol. 2020 Jan;55(1):81–86.

79

Volpe P, Muto B, Passamonti U, Rembouskos G, De Robertis V, Campobasso G, Tempesta A, Volpe G, Fanelli T. Abnormal sonographic appearance of posterior brain at 11–14 weeks and fetal outcome. Prenat Diagn. 2015 Jul;35(7):717–23.

80

Volpe P, De Robertis V, Volpe G, Boito S, Fanelli T, Olivieri C, Votino C, Persico N. Position of the choroid plexus of the fourth ventricle in first- and second-trimester fetuses: a novel approach to early diagnosis of cystic posterior fossa anomalies. Ultrasound Obstet Gynecol. 2021 Oct;58(4):568–575.

81

Labrosse KB, Buechel J, Guelmez H, Butenschoen A, Schoenberger H, Visca E, Schoetzau A, Manegold-Brauer G. Presentation of ventriculomegaly at 11–14 weeks of gestation: an analysis of longitudinal data. Prenat Diagn. 2023 Jul;43(7):910–918.

82

Senat MV, Bernard JP, Delezoide A, Saugier-Veber P, Hillion Y, Roume J, Ville Y. Prenatal diagnosis of hydrocephalus-stenosis of the aqueduct of Sylvius by ultrasound in the first trimester of pregnancy: report of two cases. Prenat Diagn. 2001 Dec;21(13):1129–32.

83

Yang YD, Li DZ. Adducted thumb in the first trimester of pregnancy: an early clue to prenatal diagnosis of L1 syndrome. J Med Ultrasound. 2022 Sep;31(4):331–333.

84

Hoffman JI, Kaplan S. The incidence of congenital heart disease. J Am Coll Cardiol. 2002;39:1890–1900.

85

Wiechec M, Nocun A, Beithon J. Early fetal echocardiography at the time of 11+0–13+6 weeks scan. Donald School J Ultrasound Obstet Gynecol. 2009;3:75–82.

86

Clur SA, Bilardo CM. Early detection of fetal cardiac abnormalities: how effective is it and how should we manage these patients? Prenat Diagn. 2014 Dec;34(13):1235–1245.

87

Karim JN, Bradburn E, Roberts N, Papageorghiou AT. First-trimester ultrasound detection of fetal heart anomalies: systematic review and meta-analysis. Ultrasound Obstet Gynecol. 2022 Jan;59(1):11–25.

88

Minnella GP, Crupano FM, Syngelaki A, Zidere V, Akolekar R, Nicolaides KH. Diagnosis of major heart defects by routine first-trimester ultrasound examination: association with increased nuchal translucency, tricuspid regurgitation and abnormal flow in ductus venosus. Ultrasound Obstet Gynecol. 2020 May;55(5):637–644.

89

Abu-Rustum RS, Ziade MF, Abu-Rustum SE. Learning curve and factors influencing the feasibility of performing fetal echocardiography at the time of the first-trimester scan. J Ultrasound Med. 2011 May;30(5):695–700.

90

Huggon IC, Ghi T, Cook AC, Zosmer N, Allan LD, Nicolaides KH. Fetal cardiac abnormalities identified prior to 14 weeks' gestation. Ultrasound Obstet Gynecol. 2002 Jul;20(1):22–29.

91

Rieder W, Eperon I, Meagher S. Congenital heart anomalies in the first trimester: from screening to diagnosis. Prenat Diagn. 2023 Jul;43(7):889–900.

92

Turan S, Goetzinger KR. First-trimester fetal heart evaluation: time to move forward. Ultrasound Obstet Gynecol. 2021 Jun;57(6):677–680.

93

Liao Y, Wen H, Ouyang S, Yuan Y, Bi J, Guan Y, Fu Q, Yang X, Guo W, Huang Y, Zeng Q, Qin Y, Xiang H, Li S. Routine first-trimester ultrasound screening using a standardized anatomical protocol. Am J Obstet Gynecol. 2021 Apr;224(4):396.e1–396.e15.

94

Escobar-Diaz MC, Freud LR, Bueno A, Brown DW, Friedman KG, Schidlow D, Emani S, Del Nido PJ, Tworetzky W. Prenatal diagnosis of transposition of the great arteries over a 20-year period: improved but imperfect. Ultrasound Obstet Gynecol. 2015 Jun;45(6):678–682.

95

Votino C, Cos T, Abu-Rustum R, Dahman Saidi S, Gallo V, Dobrescu O, Dessy H, Jani J. Use of spatiotemporal image correlation at 11–14 weeks' gestation. Ultrasound Obstet Gynecol. 2013 Nov;42(6):669–678.

96

Papatheodorou SI, Evangelou E, Makrydimas G, Ioannidis JP. First-trimester ductus venosus screening for cardiac defects: a meta-analysis. BJOG. 2011 Dec;118(12):1438–1445.

97

Pereira S, Ganapathy R, Syngelaki A, Maiz N, Nicolaides KH. Contribution of fetal tricuspid regurgitation in first-trimester screening for major cardiac defects. Obstet Gynecol. 2011 Jun;117(6):1384–1391.

98

Clur SA, Mathijssen IB, Pajkrt E, Cook A, Laurini RN, Ottenkamp J, Bilardo CM. Structural heart defects associated with an increased nuchal translucency: 9 years experience in a referral centre. Prenat Diagn. 2008 Apr;28(4):347–354.

99

Timmerman E, Oude Rengerink K, Pajkrt E, Opmeer BC, van der Post JA, Bilardo CM. Ductus venosus pulsatility index measurement reduces the false-positive rate in first-trimester screening. Ultrasound Obstet Gynecol. 2010 Dec;36(6):661–667.

100

Maiz N, Plasencia W, Dagklis T, Faros E, Nicolaides K. Ductus venosus Doppler in fetuses with cardiac defects and increased nuchal translucency. Ultrasound Obstet Gynecol. 2008 Mar;31(3):256–260.

101

Kiserud T, Eik-Nes SH, Blaas HG, Hellevik LR, Simensen B. Ductus venosus blood velocity changes in fetal cardiac disease. J Matern Fetal Invest. 1993 Jan;3(1):15–20.

102

Sinkovskaya ES, Chaoui R, Karl K, Andreeva E, Zhuchenko L, Abuhamad AZ. Fetal cardiac axis and congenital heart defects in early gestation. Obstet Gynecol. 2015 Feb;125(2):453–460.

103

Bakker M, Pace M, de Jong-Pleij E, Birnie E, Kagan KO, Bilardo CM. Prenasal thickness, prefrontal space ratio and other facial profile markers in first-trimester fetuses with aneuploidies, cleft palate, and micrognathia. Fetal Diagn Ther. 2016 Nov;40(6):432–440.

104

Sepulveda W, Wong AE, Martinez-Ten P, Perez-Pedregosa J. Retronasal triangle: a sonographic landmark for the screening of cleft palate in the first trimester. Ultrasound Obstet Gynecol. 2010 Jan;35(1):7–13.

105

Sepulveda W, Wong AE, Viñals F, Andreeva E, Adzehova N, Martinez-Ten P. Absent mandibular gap in the retronasal triangle view: a clue to the diagnosis of micrognathia in the first trimester. Ultrasound Obstet Gynecol. 2012 Feb;39(2):152–156.

106

Chaoui R, Orosz G, Heling KS, Sarut-Lopez A, Nicolaides KH. Maxillary gap at 11–13 weeks' gestation: marker of cleft lip and palate. Ultrasound Obstet Gynecol. 2015 Dec;46(6):665–669.

107

Lakshmy SR, Deepa S, Rose N, Mookan S, Agnees J. First trimester sonographic evaluation of palatine clefts: a novel diagnostic approach. J Ultrasound Med. 2017;36(7):1397–1414.

108

Li X, Xiu G, Yan F, Hou Q, Chen C, Dong X, Liu H. First-Trimester Evaluation of Cleft Lip and Palate by A Novel Two-Dimensional Sonographic Technique: A Prospective Study. Curr Med Imaging. 2023;19(3):278–285.

109

Cavoretto P, Molina F, Poggi S, Davenport M, Nicolaides KH. Prenatal diagnosis and outcome of echogenic fetal lung lesions. Ultrasound Obstet Gynecol. 2008 Nov;32(6):769–783.

110

Gilboa Y, Achiron R, Katorza E, Bronshtein M. Early sonographic diagnosis of congenital high-airway obstruction syndrome. Ultrasound Obstet Gynecol. 2009 Jun;33(6):731–733.

111

Sebire NJ, Snijders RJ, Davenport M, Greenough A, Nicolaides KH. Fetal nuchal translucency thickness at 10–14 weeks' gestation and congenital diaphragmatic hernia. Obstet Gynecol. 1997 Dec;90(6):943–946.

112

Erculiani M, Trovalusci E, Zanatta C, De Lorenzis MS, Filippi E, Bracalente G, Midrio P. First trimester lower abdominal cysts as early predictor of anorectal malformations. J Ultrasound. 2023 Jun;26(2):543–548.

113

Bronshtein M, Amit A, Achiron R, Noy I, Blumenfeld Z. The early prenatal sonographic diagnosis of renal agenesis: techniques and possible pitfalls. Prenat Diagn. 1994 Apr;14(4):291–297.

114

Sepulveda W, Sebire NJ, Souka A, Snijders RJ, Nicolaides KH. Diagnosis of the Meckel-Gruber syndrome at eleven to fourteen weeks' gestation. Am J Obstet Gynecol 1997;176(2):316–319.

115

Khalil A, Pajkrt E, Chitty LS. Early prenatal diagnosis of skeletal anomalies. Prenat Diagn. 2011 Jan;31(1):115–124.

116

Chitty LS, Mason S, Barrett AN, McKay F, Lench N, Daley R, Jenkins LA. Non-invasive prenatal diagnosis of achondroplasia and thanatophoric dysplasia: next-generation sequencing allows for a safer, more accurate, and comprehensive approach. Prenat Diagn. 2015 Jul;35(7):656–662.

117

Yan H, Zhu X, Chen J, Cao Y, Kwok YKY, Chen Z, Leung TY, Chen M, Choy KW. Non-invasive prenatal sequencing for multiple Mendelian monogenic disorders among fetuses with skeletal dysplasia or increased nuchal translucency. Prenat Diagn. 2020 Oct;40(11):1459–1465.

118

Gadsbøll K, Vogel I, Pedersen LH, Kristensen SE, Steffensen EH, Wright A, Wright D, Hyett J, Petersen OB; Danish Cytogenetic Central Registry study group. Decoding 22q11.2: prenatal profiling and first-trimester risk assessment in Danish nationwide cohort. Ultrasound Obstet Gynecol. 2024 Jan;63(1):34–43.

119

Mellis R, Oprych K, Scotchman E, Hill M, Chitty LS. Diagnostic yield of exome sequencing for prenatal diagnosis of fetal structural anomalies: a systematic review and meta-analysis. Prenat Diagn. 2022; 42(6): 662–685.

120

Mone F, Abu Subieh H, Doyle S, Hamilton S, Mcmullan DJ, Allen S, Marton T, Williams D, Kilby MD. Evolving fetal phenotypes and clinical impact of progressive prenatal exome sequencing pathways: cohort study. Ultrasound Obstet Gynecol. 2022 Jun;59(6):723–730.

121

Bardi F, Bakker M, Kenkhuis MJA, Ranchor AV, Bakker MK, Elvan A, Birnie E, Bilardo CM. Psychological outcomes, knowledge and preferences of pregnant women on first-trimester screening for fetal structural abnormalities: A prospective cohort study. PLoS One. 2021 Jan 27;16(1):e0245938.

122

Bronsgeest K, Lust EER, Henneman L, Crombag N, Bilardo CM, Stemkens D, Galjaard RH, Sikkel E, van der Hout SH, Bekker MN, Haak MC. Current practice of first-trimester ultrasound screening for structural fetal anomalies in developed countries. Prenat Diagn. 2023;43(7):873–880.

123

Bardi F, Kagan KO, Bilardo CM. First-trimester screening strategies: A balance between costs, efficiency and diagnostic yield. Prenatal Diagnosis 2023;43(7):865–872.

124

Bardi F, Beekhuis AM, Bakker MK, Elvan-Taşpınar A, Bilardo CM. Timing of diagnosis of fetal structural abnormalities after the introduction of universal cell-free DNA in the absence of first-trimester anatomical screening. Prenat Diagn. 2022 Sep;42(10):1242–1252.

125

Ungureanu A, Marcu AS, Patru CL, Ruican D, Nagy R, Stoean R, Stoean C, Iliescu DG. Learning deep architectures for the interpretation of first-trimester fetal echocardiography (LIFE) – a study protocol for developing an automated intelligent decision support system for early fetal echocardiography. BMC Pregnancy Childbirth. 2023 Jan 11;23(1):20.

126

Pietersma CS, Mulders AGMGJ, Moolenaar LM, Hunink MGM, Koning AHJ, Willemsen SP, Go ATJI, Steegers EAP, Rousian M. First trimester anomaly scan using virtual reality (VR FETUS study): study protocol for a randomized clinical trial. BMC Pregnancy Childbirth. 2020 Sep 7;20(1):515.

127

Rolnik DL, Wertaschnigg D, Benoit B, Meagher S. Sonographic detection of fetal abnormalities before 11 weeks of gestation. Ultrasound Obstet Gynecol. 2020 May;55(5):565–574.

128

Lust EER, Bronsgeest K, Henneman L, Crombag N, Bilardo CM, Galjaard RH, Sikkel E, van der Hout S, Coumans A, Elvan-Taşpınar A, Go ATJI, Galjaard S, Manten GTR, Pajkrt E, van Leeuwen L, Haak MC, Bekker MN. Introduction of a nationwide first-trimester anomaly scan in the Dutch national screening program. Am J Obstet Gynecol. 2024 Jul 25:S0002–9378(24)00785–3.

129

Spingler T, Sonek J, Hoopmann M, Prodan N, Abele H, Kagan KO. Complication rate after termination of pregnancy for fetal defects. Ultrasound Obstet Gynecol. 2023 Jul;62(1):88-93. 

Online Study Assessment Option
All readers who are qualified doctors or allied medical professionals can now automatically receive 2 Continuing Professional Development credits from FIGO plus a Study Completion Certificate from GLOWM for successfully answering 4 multiple choice questions (randomly selected) based on the study of this chapter.
Medical students can receive the Study Completion Certificate only.

 

(To find out more about FIGO’s Continuing Professional Development awards programme CLICK HERE)